Published in Curr Opin Infect Dis on October 01, 2009
Factors that explain excretion of enteric pathogens by persons without diarrhea. Clin Infect Dis (2012) 1.09
Family 6 glycosyltransferases in vertebrates and bacteria: inactivation and horizontal gene transfer may enhance mutualism between vertebrates and bacteria. J Biol Chem (2010) 0.85
Whole-genome sequencing targets drug-resistant bacterial infections. Hum Genomics (2015) 0.84
Immunological alterations mediated by adenosine during host-microbial interactions. Immunol Res (2011) 0.81
Genetic, molecular and physiological basis of variation in Drosophila gut immunocompetence. Nat Commun (2015) 0.80
A genomic analysis of Clostridium difficile infections in blunt trauma patients. J Trauma Acute Care Surg (2013) 0.77
A genome-wide association meta-analysis of diarrhoeal disease in young children identifies FUT2 locus and provides plausible biological pathways. Hum Mol Genet (2016) 0.76
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet (2000) 8.79
Human susceptibility and resistance to Norwalk virus infection. Nat Med (2003) 7.07
Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe (2008) 4.14
No association between histo-blood group antigens and susceptibility to clinical infections with genogroup II norovirus. J Infect Dis (2008) 3.04
The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis. J Immunol (2006) 2.83
Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh. PLoS Negl Trop Dis (2008) 2.48
Outbreak studies of a GII-3 and a GII-4 norovirus revealed an association between HBGA phenotypes and viral infection. J Med Virol (2008) 1.81
Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity. Infect Immun (2005) 1.79
Association of interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with Clostridium difficile-associated diarrhea. Clin Gastroenterol Hepatol (2007) 1.41
Influence of human leukocyte antigen class II alleles on susceptibility to Entamoeba histolytica infection in Bangladeshi children. J Infect Dis (2004) 1.31
Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region. J Infect Dis (2003) 1.30
Enteric infection meets intestinal function: how bacterial pathogens cause diarrhoea. Nat Rev Microbiol (2008) 1.22
Genes of the class II and class III major histocompatibility complex are associated with typhoid fever in Vietnam. J Infect Dis (2000) 1.20
Crohn's disease patients homozygous for the 3020insC NOD2 mutation have a defective NOD2/TLR4 cross-tolerance to intestinal stimuli. Immunology (2007) 1.12
A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico. Clin Infect Dis (2007) 1.09
A common polymorphism in the interleukin 8 gene promoter is associated with Clostridium difficile diarrhea. Am J Gastroenterol (2006) 1.06
A variant in long palate, lung and nasal epithelium clone 1 is associated with cholera in a Bangladeshi population. Genes Immun (2009) 1.01
Blood group antigen recognition by Escherichia coli heat-labile enterotoxin. J Mol Biol (2007) 0.99
Association between Cryptosporidium infection and human leukocyte antigen class I and class II alleles. J Infect Dis (2008) 0.99
Genetic polymorphisms of CD14, toll-like receptor 4, and caspase-recruitment domain 15 are not associated with necrotizing enterocolitis in very low birth weight infants. J Pediatr Gastroenterol Nutr (2006) 0.98
Susceptibility to typhoid fever is associated with a polymorphism in the cystic fibrosis transmembrane conductance regulator (CFTR). Hum Genet (2005) 0.93
Influence of host interleukin-10 polymorphisms on development of traveler's diarrhea due to heat-labile enterotoxin-producing Escherichia coli in travelers from the United States who are visiting Mexico. Clin Vaccine Immunol (2008) 0.93
Polymorphisms in proinflammatory genes and susceptibility to typhoid fever and paratyphoid fever. J Interferon Cytokine Res (2007) 0.85
A TNF region haplotype offers protection from typhoid fever in Vietnamese patients. Hum Genet (2007) 0.82
Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. Lancet (2008) 2.79
A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea. Ann Intern Med (2005) 2.58
Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone. Clin Gastroenterol Hepatol (2007) 2.37
A review of an emerging enteric pathogen: enteroaggregative Escherichia coli. J Med Microbiol (2006) 1.54
A functional collagen adhesin gene, acm, in clinical isolates of Enterococcus faecium correlates with the recent success of this emerging nosocomial pathogen. Infect Immun (2008) 1.47
Persistent abdominal symptoms in US adults after short-term stay in Mexico. J Travel Med (2014) 1.47
Seroepidemiology of norovirus-associated travelers' diarrhea. J Travel Med (2014) 1.43
Enteroaggregative Escherichia coli is a cause of acute diarrheal illness: a meta-analysis. Clin Infect Dis (2006) 1.38
Cryptosporidium hominis: experimental challenge of healthy adults. Am J Trop Med Hyg (2006) 1.35
Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region. J Infect Dis (2003) 1.30
HIV1 and the gut in the era of highly active antiretroviral therapy. Curr Gastroenterol Rep (2002) 1.25
A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone. Pharmacotherapy (2005) 1.18
Enteroaggregative Escherichia coli: an emerging enteric pathogen. Am J Gastroenterol (2004) 1.18
Cryptosporidiosis. Curr Opin Infect Dis (2002) 1.17
Enteroaggregative Escherichia coli infection. Curr Opin Gastroenterol (2009) 1.14
Association of putative enteroaggregative Escherichia coli virulence genes and biofilm production in isolates from travelers to developing countries. J Clin Microbiol (2006) 1.09
A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico. Clin Infect Dis (2007) 1.09
Molecular epidemiology of the fsr locus and of gelatinase production among different subsets of Enterococcus faecalis isolates. J Clin Microbiol (2004) 1.06
Cryptosporidiosis in children. Semin Pediatr Infect Dis (2004) 1.05
Virulence characteristics and the molecular epidemiology of enteroaggregative Escherichia coli isolates from travellers to developing countries. J Med Microbiol (2007) 1.03
Noroviruses as a cause of traveler's diarrhea among students from the United States visiting Mexico. J Clin Microbiol (2005) 1.03
Interleukin-8 response in an intestinal HCT-8 cell line infected with enteroaggregative and enterotoxigenic Escherichia coli. Clin Diagn Lab Immunol (2004) 1.02
Interleukin-8, tumor necrosis factor-alpha, and lactoferrin in immunocompetent hosts with experimental and Brazilian children with acquired cryptosporidiosis. Am J Trop Med Hyg (2003) 1.01
Enteropathogens and chronic illness in returning travelers. N Engl J Med (2013) 0.99
Cryptosporidium dose-response studies: variation between hosts. Risk Anal (2002) 0.99
PCR-based assay using occult blood detection cards for detection of diarrheagenic Escherichia coli in specimens from U.S. travelers to Mexico with acute diarrhea. J Clin Microbiol (2008) 0.95
Enteroaggregative Escherichia coli (EAEC): a cause of acute and persistent diarrhea of worldwide importance. J Infect Dis (2010) 0.93
Mechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic. Proc Natl Acad Sci U S A (2013) 0.93
Influence of host interleukin-10 polymorphisms on development of traveler's diarrhea due to heat-labile enterotoxin-producing Escherichia coli in travelers from the United States who are visiting Mexico. Clin Vaccine Immunol (2008) 0.93
Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico. J Clin Microbiol (2010) 0.92
Enterotoxigenic Escherichia coli heat-labile toxin seroconversion in US travelers to Mexico. J Travel Med (2008) 0.92
Patterns of illness in travelers visiting Mexico and Central America: the GeoSentinel experience. Clin Infect Dis (2011) 0.90
Rifaximin treatment of pathogen-negative travelers' diarrhea. J Travel Med (2007) 0.90
Fecal cytokines and markers of intestinal inflammation in international travelers with diarrhea due to Noroviruses. J Med Virol (2006) 0.90
Cryptosporidium meleagridis: infectivity in healthy adult volunteers. Am J Trop Med Hyg (2011) 0.89
Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone. J Travel Med (2007) 0.89
Seroprevalence of the enteroaggregative Escherichia coli virulence factor dispersin among USA travellers to Cuernavaca, Mexico: a pilot study. J Med Microbiol (2008) 0.85
Single nucleotide polymorphisms in the promoter of the gene encoding the lipopolysaccharide receptor CD14 are associated with bacterial diarrhea in US and Canadian travelers to Mexico. Clin Infect Dis (2011) 0.85
Cryptosporidium dose response studies: variation between isolates. Risk Anal (2002) 0.85
Cryptosporidium muris in a Texas canine population. Am J Trop Med Hyg (2008) 0.85
Seasonality of diarrheagenic Escherichia coli pathotypes in the US students acquiring diarrhea in Mexico. J Travel Med (2011) 0.84
Prevention of travelers' diarrhea with rifaximin in US travelers to Mexico. J Travel Med (2010) 0.82
Biochemical and genetic diversity of enterotoxigenic Escherichia coli associated with diarrhea in United States students in Cuernavaca and Guadalajara, Mexico, 2004-2007. J Infect Dis (2010) 0.82
High levels of CXCL10 are produced by intestinal epithelial cells in AIDS patients with active cryptosporidiosis but not after reconstitution of immunity. Infect Immun (2006) 0.82
A randomized, double-blind, pilot study of rifaximin 550 mg versus placebo in the prevention of travelers' diarrhea in Mexico during the dry season. J Travel Med (2011) 0.82
Substance P expression correlates with severity of diarrhea in cryptosporidiosis. J Infect Dis (2003) 0.81
Epidemiology of cryptosporidiosis in North American travelers to Mexico. Am J Trop Med Hyg (2008) 0.81
Characterization of aminopeptidase activity from three species of microsporidia: Encephalitozoon cuniculi, Encephalitozoon hellem, and Vittaforma corneae. J Parasitol (2002) 0.79
Evaluation of recombinant oocyst protein CP41 for detection of cryptosporidium-specific antibodies. Clin Diagn Lab Immunol (2005) 0.78
Antibacterial chemoprophylaxis in the prevention of traveler's diarrhea: evaluation of poorly absorbed oral rifaximin. Clin Infect Dis (2005) 0.78
Cryptosporidium parvum: identification and characterization of an acid phosphatase. Parasitol Res (2007) 0.78
Human studies provide insight into the pathogenesis, immunology, and treatment of cryptosporidiosis. Clin Infect Dis (2003) 0.77
Molecular cloning and analysis of the Cryptosporidium parvum aminopeptidase N gene. Int J Parasitol (2002) 0.76
Pilot study of whole-blood gamma interferon response to the Vibrio cholerae toxin B subunit and resistance to enterotoxigenic Escherichia coli-associated diarrhea. Clin Vaccine Immunol (2010) 0.75
Campylobacter jejuni is not an important pathogen as a cause of diarrhea in US travelers to Mexico. J Travel Med (2010) 0.75
Treatment of chronic cryptosporidiosis in AIDS with rIL-12 induces an immune response associated with improvement but severe side-effects. AIDS (2005) 0.75